Medlife Crisis on MSN

Why the history of heart science reveals more about humanity than anatomy

From ancient philosophers who saw the heart as the seat of the soul to modern cardiologists mapping electrical impulses, ...
pharmaphorum

Novo's oral GLP-1 is first to claim heart health label

Novo Nordisk's Rybelsus has become the first oral GLP-1 agonist to pick up a regulatory approval for cardiovascular risk reduction, after getting a green light from the EMA's human medicine committee.